Occurrence of the carbapenem-hydrolyzing β-lactamase gene bla OXA-48 in the environment in Morocco

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 11, 2011, Pages 5413-5414

  Potron, Anaïs ^a   Poirel, Laurent ^a   Bussy, Florence ^a   Nordmann, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CLAVULANATE POTASSIUM PLUS TICARCILLIN; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TETRACYCLINE; TICARCILLIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE AMPLIFICATION; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOROCCO; PRIORITY JOURNAL; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MOROCCO; PLASMIDS; SERRATIA MARCESCENS;

EID: 80054696984     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05120-11     Document Type: Letter

References (14)

1. Aubert, D., T. Naas, C. Héritier, L. Poirel, and P. Nordmann. 2006. Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of β-lactam resistance genes. J. Bacteriol. 188:6506-6514. (Pubitemid 44412060)
2. Benouda, A., O. Touzani, M. T. Khairallah, G. F. Araj, and G. M. Matar. 2010. First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco. Ann. Trop. Med. Parasitol. 104:327-330.
3. Carrër, A., et al. 2008. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob. Agents Chemother. 52:2950-2954.
4. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Cuzon, G., J. Ouanich, R. Gondret, T. Naas, and P. Nordmann. 2011. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Western Europe, France. Antimicrob. Agents Chemother. 55: 2420-2423.
6. Decré, D., et al. 2010. Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010. Eurosurveillance 15:pii19718.
7. Ktari, S., et al. 2011. Spread of Klebsiella pneumoniae isolates producing OXA-48 β-lactamase in a Tunisian university hospital. J. Antimicrob. Ther. 66:1644-1646.
8. Mammeri, H., L. Poirel, P. Bémer, H. Drugeon, and P. Nordmann. 2004. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 48:716-720. (Pubitemid 38280315)
9. Moquet, O., et al. 2011. Class D OXA-48 carbapenemase in multidrugresistant enterobacteria, Senegal. Emerg. Infect. Dis. 17:143-144.
10. Poirel, L., C. Héritier, and P. Nordmann. 2004. Chromosome-encoded Ambler class D β-lactamase of Shewanella oneidensis as a progenitor of carbapenem- hydrolyzing oxacillinase. Antimicrob. Agents Chemother. 48:348-351. (Pubitemid 38040222)
11. Poirel, L., C. Héritier, V. Tolün, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22. (Pubitemid 38040171)
12. Poirel, L., et al. 2011. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. J. Antimicrob. Chemother. 66: 1181-1182.
13. Poirel, L., T. R. Walsh, V. Cuvillier, and P. Nordmann. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119-123.
14. Walsh, T. R., J. Weeks, D. M. Livermore, and M. A. Toleman. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implication for human health: an environmental point prevalence study. Lancet Infect. Dis. 11:355-362.